Cimzia and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cimzia (certolizumab pegol) and Reglan (metoclopramide hydrochloride). Common drug interactions include pallor among females and intestinal obstruction among males.

The phase IV clinical study analyzes what interactions people have when they take Cimzia and Reglan. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

65 people who take Cimzia and Reglan together, and have interactions are studied.

Cimzia and Reglan drug interactions.

What are the common drug interactions of Cimzia and Reglan, by gender? *:

female:

  1. Pallor
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Pleurisy viral (inflammation of the pleurae, which causes pain when breathing by viral infection)
  4. Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
  5. Pregnancy
  6. Pruritus generalised (generalized itching)
  7. Upper limb fracture
  8. Upper respiratory tract infection
  9. Vulvovaginal injury
  10. Anal abscess

male:

  1. Intestinal obstruction
  2. Urinary tract infection
  3. Acute respiratory distress syndrome
  4. Dehydration (dryness resulting from the removal of water)
  5. Dental caries
  6. Drug ineffective
  7. Faecal incontinence (a lack of control over passing stool)
  8. Failure to thrive (inadequate weight gain and physical growth in children)
  9. Loose tooth
  10. Nail disorder (disease of nail)

What are the common drug interactions of Cimzia and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Gastric ulcer haemorrhage (bleeding ulcer of stomach)
  2. Gastrointestinal hypomotility (less activity of the intestinal tract)
  3. International normalised ratio increased
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Blood pressure increased
  6. Breast pain
  7. Burning sensation
  8. Diarrhoea
  9. Fatigue (feeling of tiredness)
  10. Infection

30-39:

  1. Dehydration (dryness resulting from the removal of water)
  2. Urinary tract infection
  3. Acute respiratory distress syndrome
  4. Anal abscess
  5. Drug ineffective
  6. Faecal incontinence (a lack of control over passing stool)
  7. Failure to thrive (inadequate weight gain and physical growth in children)
  8. Impaired gastric emptying
  9. Insomnia (sleeplessness)
  10. Muscle spasms (muscle contraction)

40-49:

  1. Purulent discharge (discharge that contains pus)
  2. Rash
  3. Swelling face
  4. Vagus nerve disorder
  5. Abdominal pain
  6. Cellulitis (infection under the skin)
  7. Chills (felling of cold)
  8. Pain
  9. Rectal haemorrhage (bleeding from anus)
  10. Vulval abscess

50-59:

  1. Urinary tract infection
  2. Fatigue (feeling of tiredness)
  3. Fall
  4. Humerus fracture (injury to the upper arm bone)
  5. Intestinal obstruction
  6. Vomiting
  7. Alopecia (absence of hair from areas of the body)
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Blood glucose increased
  10. Candidiasis (candidiasis or thrush is a fungal infection)

60+:

  1. Urinary tract infection
  2. Renal failure acute (rapid kidney dysfunction)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Faecaloma (hard mass of fecal matter)
  5. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  6. Hydronephrosis (water inside the kidney)
  7. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  8. Joint swelling
  9. Kidney transplant rejection
  10. Left ventricular failure (left ventricle fails to contract forcefully)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 28 people, 43.08%
  2. Pain: 10 people, 15.38%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 9.23%
  4. Nausea (feeling of having an urge to vomit): 4 people, 6.15%
  5. High Blood Pressure: 4 people, 6.15%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Cimzia and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cimzia and Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cimzia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cimzia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on certolizumab pegol and metoclopramide hydrochloride (the active ingredients of Cimzia and Reglan, respectively), and Cimzia and Reglan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: